ORIGINAL PAPER
Multiple cardiac tumours as a biomarker of tuberous sclerosis complex in children below two years of age
More details
Hide details
Publication date: 2018-06-07
Pediatr Pol 2018;93(2):132-138
KEYWORDS
ABSTRACT
Introduction:
Tuberous sclerosis complex (TSC) is a neurocutaneous disorder affecting 1 in 6,000 individuals. In the course of TSC multiple, usually benign tumours develop in many organs. Moreover, 70-90% of TSC patients develop epilepsy, mostly in the first months of life. Seizures are also associated with cognitive impairment. Recent studies showed the beneficial role of preventative antiepileptic treatment in TSC. Therefore, early TSC diagnosis is becoming pivotal for epilepsy management. Cardiac rhabdomyomas are frequent and are the earliest detectable signs of TSC. They are often revealed prenatally.
Aim of the study:
To assess and compare the incidence of TSC among children with single and multiple cardiac tumours
Material and methods:
A retrospective chart review was performed in 76 children with single or multiple cardiac tumours, who were referred to the Children’s Memorial Health Institute for further diagnosis of TSC.
Results:
Single and multiple cardiac tumours were observed in 14.5% and 85.5% of patients, respectively, and 71.1% of tumours were diagnosed prenatally. The diagnosis of TSC was established in 92.1% of children. The correlation between multiple tumours and TSC diagnosis was observed (p < 0.01). Moreover, in the group of children with multiple cardiac lesions TSC was diagnosed more often than in the group with single tumours (95.4% vs. 72.7%, p < 0.05).
Conclusions:
Tuberous sclerosis complex may be diagnosed both in patients with single and multiple cardiac rhabdomyomas. However, in patients with multiple lesions TSC is confirmed significantly more often. Therefore, multiple cardiac tumours may be considered as an early biomarker of TSC.
REFERENCES (26)
1.
Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet 2008; 372: 657-668.
2.
Northrup H, Krueger DA and on behalf of the International Tuberous Sclerosis Complex Consensus Group. Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 2013; 49: 243-254.
3.
Uzun O, Wislon DG, Vujanic GM i wsp. Cardiac tumors in children. Orphanet J Rare Dis 2007; 2: 1-14.
4.
Hinton RB, Prakash A, Romp RL i wsp. Cardiovascular Manifestations of Tuberous Sclerosis Complex and Summary of the Revised Diagnostic Criteria and Surveillance and Management Recommendations From the International Tuberous Sclerosis Consensus Group. J Am Heart Assoc 2014; 3: 1-11.
5.
Więckowska K, Piątek K, Respondek-Liberska M. Heart Tumors in 33 fetuses – review of twenty-two years of the single-centre experience. Prenat Cardiol 2016; 6: 22-30.
6.
Jozwiak S, Kotulska K, Domanska-Pakiela D i wsp. Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex. Eur J Pediatr Neurol 2011; 15: 424-431.
7.
Niewiadomska-Jarosik K, Stańczyk J, Janiak K i wsp. Prenatal diagnosis and follow-up of 23 cases of cardiac tumors. Prenat Diagn 2010; 30: 882-887.
8.
Józwiak S, Schwartz RA, Janniger CK i wsp. Usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients. J Child Neurol 2000; 15: 652-659.
9.
Tworetzky W, McElhinney DB, Margossian R i wsp. Association between cardiac tumors and Tuberous Sclerosis in the fetus and neonate. Am J Cardiol 2003; 92: 487-489.
10.
Jóźwiak S, Kotulska K, Kasprzyk-Obara J i wsp. Clinical and genotype studies of cardiac tumors in 154 patients with tuberous sclerosis complex. Pediatrics 2006; 118: e1146-1151.
11.
EPISTOP. Long-term, prospective study evaluating clinical and molecular biomarkers of epileptogenesis in a genetic model of epilepsy – tuberous sclerosis complex.
http://www.epistop.eu/ (dostęp: 15.09.2017).
12.
Chu-Shore CJ, Major P, Camposano S i wsp. The natural history of epilepsy in tuberous sclerosis complex. Epilepsia 2010; 51: 1236-1241.
13.
Bolton PF, Clifford M, Tye C i wsp. Intellectual abilities in tuberous sclerosis complex: risk factors and correlates from the Tuberous Sclerosis 2000 Study. Psychol Med 2015; 45: 2321-2331.
14.
Wu JY, Peters JM, Goyal M i wsp. Clinical Electroencephalographic Biomarker for Impending Epilepsy in Asymptomatic Tuberous Sclerosis Complex Infants. Pediatr Neurol 2016; 54: 29-34.
15.
Cusmai R, Moavero R, Bombardieri R i wsp. Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis. Epilepsy Behav 2011; 22: 735-739.
16.
Curatolo P, Jozwiak S, Nabbout R, TSC Consensus Meeting for SEGA and Epilepsy Management. Management of epilepsy associated with tuberous sclerosis complex (TSC): Clinical recommendations. Eur J Pediatr Neurol 2012; 16: 582-586.
17.
Sciacca P, Giacchi V, Mattia C i wsp. Rhabdomyomas and Tuberous sclerosis complex: our experience in 33 cases. BMC Cardiovasc Disord 2014; 14: 1-11.
18.
Shepherd CW, Gomez MR, Lie JT i wsp. Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 1991; 66: 792-796.
19.
Krueger DA, Northrup H and on behalf of the International Tuberous Sclerosis Complex Consensus Group. Tuberous Sclerosis Complex Surveillance and Management. Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 2013; 49: 255-265.
20.
Khanna PC, Godinho S, Pungavkar SA i wsp. Ultrafast MRI in prenatal diagnosis of Bourneville’s tuberous sclerosis. Neurol India 2005; 53: 349-350.
21.
Levine D, Barnes P, Korf B i wsp. Tuberous Sclerosis in the Fetus: Second-Trimester Diagnosis of Subependymal Tubers with Ultrafast MR Imaging. AJR Am J Roentgenol 2010; 175: 1067-1069.
22.
Jurkiewicz E, Beksińska-Figatowska M, Romaniuk-Doroszewska A i wsp. Brain MRI in fetuses with cardiac tumours. Neuroradiol J 2007; 20: 494-499.
23.
Mühler MR, Rake A, Schwabe M i wsp. Value of fetal cerebral MRI in sonographically proven cardiac rhabdomyoma. Pediatr Radiol 2007; 37: 467-474.
24.
Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69: 89-95.
25.
Jóźwiak S, Domańska-Pakieła D, Kwiatkowski DJ i wsp. Multiple cardiac rhabdomyomas as a sole symptom of tuberous sclerosis complex: case report with molecular confirmation. J Child Neurol 2005; 20: 988-989.
26.
Jóźwiak S, Kotulska K. Are all prenatally diagnosed multiple cardiac rhabdomyomas a sign of tuberous sclerosis? Prenat Diagn 2006; 26: 867-869.